Tesaro's ovarian cancer drug gets EU agency backing

(Reuters) - A European Medicines Agency (EMA) panel recommended the approval of Tesaro Inc's key drug, niraparib, for the treatment of recurrent ovarian cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news